Search

everythinglearnresearchcommunity

for

Search:↓

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

The combination therapy was effective and well-tolerated, especially in young patients.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Localized hair growth and fat loss may share a common cause in lupus panniculitis.

The case suggests a possible autoimmune link between lichen sclerosus and vitiligo.

Licorice can effectively treat stomach ulcers and may work as well as or better than some standard drugs.

A new gene variant causes glucocorticoid resistance in a mother and son.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Golvatinib shows promise as a treatment for Omicron in elderly patients.